The New Zealand National Party
News from Merck that their antiviral pill, Molnupiravir, reduces the chances that patients newly diagnosed with Covid-19 will be hospitalised by about 50 per cent is incredibly encouraging and should prompt the New Zealand Government to urgently contract for this drug and other next generation Covid treatments, National’s Covid-19 spokesperson Chris Bishop says.
/Public Release. View in full here.
